Public Employees Retirement Association of Colorado Has $239,000 Position in Intrexon Corporation (XON)

Public Employees Retirement Association of Colorado reduced its stake in shares of Intrexon Corporation (NYSE:XON) by 0.2% during the first quarter, Holdings Channel reports. The firm owned 12,063 shares of the biotechnology company’s stock after selling 23 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Intrexon Corporation were worth $239,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the stock. Norges Bank purchased a new stake in Intrexon Corporation during the fourth quarter valued at approximately $17,300,000. Michael & Susan Dell Foundation purchased a new stake in Intrexon Corporation during the fourth quarter valued at approximately $10,519,000. CWM LLC raised its stake in Intrexon Corporation by 9,455.4% in the first quarter. CWM LLC now owns 35,546 shares of the biotechnology company’s stock valued at $705,000 after buying an additional 35,174 shares during the period. Opus Point Partners Management LLC purchased a new stake in Intrexon Corporation during the fourth quarter valued at approximately $240,000. Finally, Dimensional Fund Advisors LP raised its stake in Intrexon Corporation by 670.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 83,514 shares of the biotechnology company’s stock valued at $2,029,000 after buying an additional 72,675 shares during the period. Hedge funds and other institutional investors own 84.94% of the company’s stock.

Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)

Shares of Intrexon Corporation (XON) opened at 22.56 on Friday. The stock’s 50 day moving average is $22.25 and its 200 day moving average is $22.94. Intrexon Corporation has a 52 week low of $18.41 and a 52 week high of $32.90. The stock’s market cap is $2.70 billion.

Intrexon Corporation (NYSE:XON) last announced its earnings results on Wednesday, May 10th. The biotechnology company reported ($0.26) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.22) by $0.04. Intrexon Corporation had a negative net margin of 76.32% and a negative return on equity of 21.19%. The business had revenue of $53.70 million for the quarter, compared to analysts’ expectations of $49.08 million. During the same period in the prior year, the company posted ($0.55) earnings per share. The firm’s quarterly revenue was up 23.7% on a year-over-year basis. On average, equities analysts forecast that Intrexon Corporation will post ($0.92) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by WKRB News and is the property of of WKRB News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.wkrb13.com/markets/2229642/public-employees-retirement-association-of-colorado-has-239000-position-in-intrexon-corporation-xon.html.

XON has been the subject of several analyst reports. Wunderlich decreased their price objective on shares of Intrexon Corporation from $50.00 to $35.00 and set a “buy” rating for the company in a research note on Tuesday, March 14th. Stifel Nicolaus restated a “buy” rating and set a $57.00 price target on shares of Intrexon Corporation in a research note on Tuesday, April 4th. Zacks Investment Research upgraded shares of Intrexon Corporation from a “hold” rating to a “buy” rating and set a $24.00 price target for the company in a research note on Tuesday, May 2nd. Finally, BidaskClub upgraded shares of Intrexon Corporation from a “strong sell” rating to a “sell” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Intrexon Corporation has a consensus rating of “Buy” and an average target price of $40.96.

Intrexon Corporation Company Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229642/public-employees-retirement-association-of-colorado-has-239000-position-in-intrexon-corporation-xon.html

Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.